Report Summary
Eternity Insights has published a new study on Global Insomnia Therapy Market focusing on key segments as by Type (Non-pharmacological Therapy, Pharmacological Therapy, Other), by Application (Hospital, Ambulatory Surgical Center, Home Care, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Insomnia Therapy Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Insomnia Therapy Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Insomnia Therapy Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Insomnia Therapy Market Segmentation:
Insomnia Therapy Market, By Type
- Non-pharmacological Therapy
- Pharmacological Therapy
- Other
Insomnia Therapy Market, By Application
- Hospital
- Ambulatory Surgical Center
- Home Care
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Insomnia Therapy market in terms of demand generation. The Insomnia Therapy market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Insomnia Therapy market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Insomnia Therapy Market Taxonomy:
To learn more about this report
Global Insomnia Therapy Market Competitive Landscape
The global Insomnia Therapy market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Merck & Co. Inc.
- Sanofi
- Pfizer
- Inc.
- Takeda Pharmaceutical Company Ltd.
- Purdue Pharmaceuticals L.P.
- Eisai
- Co. Ltd.
- Meda Consumer Healthcare Inc.
- Pernix Therapeutics
- Vanda Pharmaceuticals
- ECR Pharmaceuticals
- Fidia Farmaceutici
- Dainippon Sumitomo
- Biocodex
- Eli Lilly and Company
- Ebb Therapeutics
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Non-pharmacological Therapy, Pharmacological Therapy, Other |
| By Application Outlook |
Hospital, Ambulatory Surgical Center, Home Care, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Merck & Co. Inc., Sanofi, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, ECR Pharmaceuticals, Fidia Farmaceutici, Dainippon Sumitomo, Biocodex, Eli Lilly and Company, Ebb Therapeutics |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Insomnia Therapy Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Insomnia Therapy Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Insomnia Therapy Market Performance
2.3 USA Insomnia Therapy Market Performance
2.4 Europe Insomnia Therapy Market Performance
2.5 Japan Insomnia Therapy Market Performance
2.6 Korea Insomnia Therapy Market Performance
2.7 India Insomnia Therapy Market Performance
2.8 Southeast Asia Insomnia Therapy Market Performance
2.9 South America Insomnia Therapy Market Performance
3 Global Insomnia Therapy Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Insomnia Therapy Market Performance (Volume)
3.3 USA Insomnia Therapy Market Performance (Volume)
3.4 Europe Insomnia Therapy Market Performance (Volume)
3.5 Japan Insomnia Therapy Market Performance (Volume)
3.6 Korea Insomnia Therapy Market Performance (Volume)
3.7 India Insomnia Therapy Market Performance (Volume)
3.8 Southeast Asia Insomnia Therapy Market Performance (Volume)
3.9 South America Insomnia Therapy Market Performance (Volume)
4 Competitive Analysis
4.1 Merck & Co. Inc.
4.1.1 Merck & Co. Inc. Profiles
4.1.2 Merck & Co. Inc. Product Information
4.1.3 Merck & Co. Inc. Insomnia Therapy Production, Revenue, Price and Gross Margin
4.1.4 Merck & Co. Inc. Insomnia Therapy Business Performance
4.1.5 SWOT Analysis
4.2 Sanofi
4.2.1 Sanofi Profiles
4.2.2 Sanofi Product Information
4.2.3 Sanofi Insomnia Therapy Production, Revenue, Price and Gross Margin
4.2.4 Sanofi Insomnia Therapy Business Performance
4.2.5 SWOT Analysis
4.3 Pfizer, Inc.
4.3.1 Pfizer, Inc. Profiles
4.3.2 Pfizer, Inc. Product Information
4.3.3 Pfizer, Inc. Insomnia Therapy Production, Revenue, Price and Gross Margin
4.3.4 Pfizer, Inc. Insomnia Therapy Business Performance
4.3.5 SWOT Analysis
4.4 Takeda Pharmaceutical Company Ltd.
4.4.1 Takeda Pharmaceutical Company Ltd. Profiles
4.4.2 Takeda Pharmaceutical Company Ltd. Product Information
4.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Production, Revenue, Price and Gross Margin
4.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Business Performance
4.4.5 SWOT Analysis
4.5 Purdue Pharmaceuticals L.P.
4.5.1 Purdue Pharmaceuticals L.P. Profiles
4.5.2 Purdue Pharmaceuticals L.P. Product Information
4.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Production, Revenue, Price and Gross Margin
4.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Business Performance
4.5.5 SWOT Analysis
4.6 Eisai, Co. Ltd.
4.6.1 Eisai, Co. Ltd. Profiles
4.6.2 Eisai, Co. Ltd. Product Information
4.6.3 Eisai, Co. Ltd. Insomnia Therapy Production, Revenue, Price and Gross Margin
4.6.4 Eisai, Co. Ltd. Insomnia Therapy Business Performance
4.6.5 SWOT Analysis
4.7 Meda Consumer Healthcare Inc.
4.7.1 Meda Consumer Healthcare Inc. Profiles
4.7.2 Meda Consumer Healthcare Inc. Product Information
4.7.3 Meda Consumer Healthcare Inc. Insomnia Therapy Production, Revenue, Price and Gross Margin
4.7.4 Meda Consumer Healthcare Inc. Insomnia Therapy Business Performance
4.7.5 SWOT Analysis
4.8 Pernix Therapeutics
4.8.1 Pernix Therapeutics Profiles
4.8.2 Pernix Therapeutics Product Information
4.8.3 Pernix Therapeutics Insomnia Therapy Production, Revenue, Price and Gross Margin
4.8.4 Pernix Therapeutics Insomnia Therapy Business Performance
4.8.5 SWOT Analysis
4.9 Vanda Pharmaceuticals
4.9.1 Vanda Pharmaceuticals Profiles
4.9.2 Vanda Pharmaceuticals Product Information
4.9.3 Vanda Pharmaceuticals Insomnia Therapy Production, Revenue, Price and Gross Margin
4.9.4 Vanda Pharmaceuticals Insomnia Therapy Business Performance
4.9.5 SWOT Analysis
4.10 ECR Pharmaceuticals
4.10.1 ECR Pharmaceuticals Profiles
4.10.2 ECR Pharmaceuticals Product Information
4.10.3 ECR Pharmaceuticals Insomnia Therapy Production, Revenue, Price and Gross Margin
4.10.4 ECR Pharmaceuticals Insomnia Therapy Business Performance
4.10.5 SWOT Analysis
4.11 Fidia Farmaceutici
4.12 Dainippon Sumitomo
4.13 Biocodex
4.14 Eli Lilly and Company
4.15 Ebb Therapeutics
5 Competitive Landscape
5.1 Global Insomnia Therapy Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Insomnia Therapy Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Insomnia Therapy Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Insomnia Therapy Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Insomnia Therapy Market Assessment by Regions
6.1 Global Insomnia Therapy Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Insomnia Therapy Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Insomnia Therapy Price (USD/Unit) by Regions (2014-2020)
6.4 Global Insomnia Therapy Gross Margin by Regions (2014-2020)
7 Insomnia Therapy Regional Analysis
7.1 China Insomnia Therapy Production, Revenue and Growth Rate (2014-2020)
7.2 USA Insomnia Therapy Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Insomnia Therapy Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Insomnia Therapy Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Insomnia Therapy Production, Revenue and Growth Rate (2014-2020)
7.6 India Insomnia Therapy Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Insomnia Therapy Production, Revenue and Growth Rate (2014-2020)
7.8 South America Insomnia Therapy Production, Revenue and Growth Rate (2014-2020)
8 Global Insomnia Therapy Consumption Assessment
8.1 Global Insomnia Therapy Consumption and Market Share by Regions (2014-2020)
8.2 Global Insomnia Therapy Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Insomnia Therapy Average Price (USD/Unit) by Regions (2014-2020)
9 Global Insomnia Therapy Sales Assessment by Regions
9.1 Global Insomnia Therapy Sales and Sales Value (2014-2020)
9.2 China Insomnia Therapy Sales and Sales Value (2014-2020)
9.3 USA Insomnia Therapy Sales and Sales Value (2014-2020)
9.4 Europe Insomnia Therapy Sales and Sales Value (2014-2020)
9.5 Japan Insomnia Therapy Sales and Sales Value (2014-2020)
9.6 Korea Insomnia Therapy Sales and Sales Value (2014-2020)
9.7 India Insomnia Therapy Sales and Sales Value (2014-2020)
9.8 Southeast Asia Insomnia Therapy Sales and Sales Value (2014-2020)
9.9 South America Insomnia Therapy Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2020-2026
12.1 Production and Revenue Forecast 2020-2026
12.1.1 Global Insomnia Therapy Production and Revenue by Regions 2020-2026
12.1.2 China Insomnia Therapy Production, Revenue and Growth Rate 2020-2026
12.1.3 USA Insomnia Therapy Production, Revenue and Growth Rate 2020-2026
12.1.4 Europe Insomnia Therapy Production, Revenue and Growth Rate 2020-2026
12.1.5 Japan Insomnia Therapy Production, Revenue and Growth Rate 2020-2026
12.1.6 Korea Insomnia Therapy Production, Revenue and Growth Rate 2020-2026
12.1.7 India Insomnia Therapy Production, Revenue and Growth Rate 2020-2026
12.1.8 Southeast Asia Insomnia Therapy Production, Revenue and Growth Rate 2020-2026
12.1.9 South America Insomnia Therapy Production, Revenue and Growth Rate 2020-2026
12.2 Sales and Sales Value Forecast 2020-2026
12.2.1 Global Insomnia Therapy Consumption and Consumption Calue by Regions 2020-2026
12.2.2 Global Insomnia Therapy Sales and Sales Value Forecast 2020-2026
12.2.3 China Insomnia Therapy Sales, Sales Value and Growth Rate 2020-2026
12.2.4 USA Insomnia Therapy Sales and Sales Value Forecast 2020-2026
12.2.5 Europe Insomnia Therapy Sales and Sales Value Forecast 2020-2026
12.2.6 Japan Insomnia Therapy Sales and Sales Value Forecast 2020-2026
12.2.7 Korea Insomnia Therapy Sales and Sales Value Forecast 2020-2026
12.2.8 India Insomnia Therapy Sales and Sales Value Forecast 2020-2026
12.2.9 Southeast Asia Insomnia Therapy Sales and Sales Value Forecast 2020-2026
12.2.10 South America Insomnia Therapy Sales and Sales Value Forecast 2020-2026
12.3 Global Insomnia Therapy Production and Revenue Forecast by Type 2020-2026
12.3.1 Overall Market Performance
12.3.2 Non-pharmacological Therapy
12.3.3 Pharmacological Therapy
12.4 Global Insomnia Therapy Sales Forecast by Application 2020-2026
12.4.1 Overall Market Performance
12.4.2 Hospital
12.4.3 Ambulatory Surgical Center
12.4.4 Home Care
12.5 Global Insomnia Therapy Price and Gross Margin Forecast
13.5.1 Global Insomnia Therapy Averages Price Development Trend Forecast 2020-2026
13.5.2 Global Insomnia Therapy Gross Margin Development Trend Forecast 2020-2026
13 Conclusion
